Streetbeat News

CHE

Chemed Corporation

https://www.chemed.com

Industry

Medical - Care Facilities

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Open

594.80

Mkt cap

8.8B

Volume

92K

High

598.53

P/E Ratio

30.12

52-wk high

653.75

Low

591.58

Div yield

0.00

52-wk low

512.12

Chemed Corporation has authorized an additional $300 million for stock repurchase and declared a quarterly dividend of 50 cents per share.

Portfolio Pulse from

November 08, 2024 | 5:00 pm

Chemed's shares declined following the release of disappointing Q3 financial results and lower-than-expected FY24 EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 4:02 pm

Chemed Corporation has revised its FY24 EPS guidance to a range of $23.00-$23.15, which is below the previous estimate of $23.58.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 8:27 pm

Chemed's Q3 2024 earnings and sales missed analyst estimates, with EPS at $5.64 versus the expected $5.76 and sales at $606.181M versus the expected $612.215M. Despite the miss, sales increased by 7.38% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 8:25 pm

Chemed's short interest has increased by 3.3%, with 243,000 shares sold short, representing 1.88% of its float. This is lower than its peers' average of 8.31%. The rise in short interest suggests a bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 5:15 pm

Chemed (NYSE:CHE) has significantly outperformed the market over the past 15 years, with an annualized return of 18.99%. A $1000 investment in Chemed 15 years ago would be worth $13,304.94 today. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 25, 2024 | 9:00 pm

Chemed (NYSE:CHE) has significantly outperformed the market over the past 20 years, with an average annual return of 16.29%. A $1000 investment in CHE 20 years ago would now be worth $20,748.94, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 2:30 pm

On CNBC's 'Final Trades,' experts discussed various stocks and ETFs. Joshua Brown recommended iShares U.S. Oil & Gas ETF as a hedge against Iran conflict. Jim Lebenthal highlighted Exxon Mobil's strong performance and potential asset sale approval in Nigeria. Kari Firestone chose Chemed, which will release Q3 results soon. Stephanie Link picked Las Vegas Sands, with a recent price target increase by Wells Fargo.

Portfolio Pulse from Avi Kapoor

October 02, 2024 | 12:59 pm

The CNBC Halftime Report highlighted final trades including Exxon Mobil, Chemed, Las Vegas Sands, and the iShares U.S. Oil & Gas Exploration & Production ETF.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:01 pm

Chemed's short interest has decreased by 14.22%, with 1.93% of its shares sold short. This is lower than its peers' average of 9.45%. The decrease in short interest may indicate a more bullish sentiment towards the stock.

Portfolio Pulse from Benzinga Insights

August 28, 2024 | 7:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.